These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 6587926)
21. Renal calcifications: a complication of long-term furosemide therapy in preterm infants. Hufnagle KG; Khan SN; Penn D; Cacciarelli A; Williams P Pediatrics; 1982 Sep; 70(3):360-3. PubMed ID: 7110808 [TBL] [Abstract][Full Text] [Related]
22. Cortical hyperostosis after administration of prostaglandin E. Dekel S; Francis MJ J Pediatr; 1981 Sep; 99(3):500-1. PubMed ID: 7021785 [No Abstract] [Full Text] [Related]
23. Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease. Ueda K; Saito A; Nakano H; Aoshima M; Yokota M; Muraoka R; Iwaya T J Pediatr; 1980 Nov; 97(5):834-6. PubMed ID: 7000997 [No Abstract] [Full Text] [Related]
24. Congenital heart disease and respiratory distress syndrome. Reversal of indomethacin closure of patent ductus arteriosus by prostaglandin therapy in a preterm infant. Strauss A; Modanlou HD; Gyepes M; Wittner R Am J Dis Child; 1982 Oct; 136(10):934-6. PubMed ID: 6889810 [TBL] [Abstract][Full Text] [Related]
25. An unusual gastric bezoar in a newborn: polystyrene resin and Candida albicans. Metlay LA; Klionsky BL J Pediatr; 1983 Jan; 102(1):121-3. PubMed ID: 6848711 [No Abstract] [Full Text] [Related]
26. Furosemide promotes patent ductus arteriosus in premature infants with the respiratory-distress syndrome. Green TP; Thompson TR; Johnson DE; Lock JE N Engl J Med; 1983 Mar; 308(13):743-8. PubMed ID: 6828120 [TBL] [Abstract][Full Text] [Related]
27. Cholelithiasis in infants: association with total parenteral nutrition and furosemide. Callahan J; Haller JO; Cacciarelli AA; Slovis TL; Friedman AP Radiology; 1982 May; 143(2):437-9. PubMed ID: 6803294 [No Abstract] [Full Text] [Related]
34. New drugs, more complications--old drugs, new complications: drug-related sequelae of neonatal intensive care. Kassner EG Bull N Y Acad Med; 1984 Jun; 60(5):504-13. PubMed ID: 6587926 [No Abstract] [Full Text] [Related]
35. Adverse drug reactions in the newborn. Kumar SP Ann Clin Lab Sci; 1985; 15(3):195-203. PubMed ID: 2986513 [TBL] [Abstract][Full Text] [Related]
36. Long-term effects of neonatal drugs on the kidney. Zaffanello M; Bassareo PP; Cataldi L; Antonucci R; Biban P; Fanos V J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():87-9. PubMed ID: 20653340 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic drug monitoring--the appropriate use of drug level measurement in the care of the neonate. Young TE Clin Perinatol; 2012 Mar; 39(1):25-31. PubMed ID: 22341534 [TBL] [Abstract][Full Text] [Related]
38. Pharmacology, selection and complications associated with neuromuscular blocking drugs in ICU patients. Prielipp RC Yale J Biol Med; 1998; 71(6):469-84. PubMed ID: 10604780 [No Abstract] [Full Text] [Related]
39. Use of prostaglandins in cardiopulmonary diseases of the newborn. Olley PM; Coceani F Semin Perinatol; 1980 Apr; 4(2):135-41. PubMed ID: 6990504 [No Abstract] [Full Text] [Related]
40. Adverse drug reactions in neonatal intensive care units. Bonati M; Marchetti F; Zullini MT; Pistotti V; Tognoni G Adverse Drug React Acute Poisoning Rev; 1990; 9(2):103-18. PubMed ID: 2220473 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]